dc.contributor.author |
Koch, Pierre |
|
dc.contributor.author |
Ansideri, Francesco |
|
dc.date.accessioned |
2019-03-22T15:24:14Z |
|
dc.date.available |
2019-03-22T15:24:14Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
1521-4184 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/87231 |
|
dc.language.iso |
en |
en |
dc.publisher |
Wiley - V C H Verlag Gmbh |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1002/ardp.201700258 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
540 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological Activity |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20190131163842_00267 |
|
utue.personen.roh |
Koch, Pierre |
|
utue.personen.roh |
Ansideri, Francesco |
|
dcterms.isPartOf.ZSTitelID |
Archiv der Pharmazie |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article e1700258 |
de_DE |
dcterms.isPartOf.ZS-Volume |
350 |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
|